Bentham Science Logo

Track Your Manuscript:

Current Neuropharmacology

Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access


Current Neuropharmacology, Volume 13 - Number 5

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

, 13(5): 558 - 576

Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre

DOI: 10.2174/1570159X13666150630171433

Treatment-resistant Late-life Depression: Challenges and Perspectives

, 13(5): 577 - 591

Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

DOI: 10.2174/1570159X1305151013200032

Pharmacological Approaches for Treatment-resistant Bipolar Disorder

, 13(5): 592 - 604

Shi Hui Poon, Kang Sim and Ross J. Baldessarini

DOI: 10.2174/1570159X13666150630171954

From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

, 13(5): 605 - 615

Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho

DOI: 10.2174/1570159X13666150630174343

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

, 13(5): 616 - 635

Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira

DOI: 10.2174/1570159X13666150630173522

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

, 13(5): 636 - 655

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho

DOI: 10.2174/1570159X13666150630175044

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

, 13(5): 656 - 662

Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean

DOI: 10.2174/1570159X13666150630175841

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

, 13(5): 663 - 680

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

DOI: 10.2174/1570159X13666150630173047

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

, 13(5): 681 - 691

Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington

DOI: 10.2174/1570159X13666150115220221

Myalgic Encephalomyelitis: Symptoms and Biomarkers

, 13(5): 701 - 734

Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn

DOI: 10.2174/1570159X13666150928105725


Ferdinando Nicoletti
University Rome"da Sapienza"
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].



Related Journals

Related eBooks

eBooks Catalog